MEMPHIS PHARMACEUTICALS & CHEMICAL INDUSTRIES Memphis Pharmaceuticals (MPCI.CA) Reports 6 Months Results
16/02/2022
16/02/2022
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Currency : EGP
F/S Period : from 01/07/2021 to 31/12/2021
Net Profit : 9,584,547
F/S Period: from 01/07/2020 to 31/12/2020
Net Comparative Profit : 18,815,819
Audit Status : Reviewed
Source : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Currency : EGP
F/S Period : from 01/07/2021 to 31/12/2021
Net Profit : 9,584,547
F/S Period: from 01/07/2020 to 31/12/2020
Net Comparative Profit : 18,815,819
Audit Status : Reviewed
Source : Memphis Pharmaceuticals
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Memphis Pharmaceuticals and Chemical Industries SAE published this content on 16 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 February 2022 07:53:01 UTC.
